IonQ's strong revenue growth and partnerships with industry leaders are promising, but high operating expenses and reliance ...

Funding for climate tech has contracted in recent years. What makes Gothenburg so unique in its ability to fund, scale and ...

As a terminal operator, shipping firm Wallenius Wilhelmsen aims to strengthen Gothenburg's role as a key hub for vehicle transport, positioning itself as an integrated supply chain partner. "Operating ...

Gothenburg Center for Sustainability Development (GMV) Private organizations and businesses, for instance RISE and AstraZeneca Public organisations such as IVL Swedish environmental research institute ...

AstraZeneca still trades at a premium valuation, but several factors limit its upside potential in the next visible period. There are three negative takeaways from China. IRA could also ...

UK-based pharmaceutical giant AstraZeneca has announced plans to restructure its biopharma unit to concentrate on next-generation therapeutics. “In the Biopharmaceutical Business Unit, we are now ...

IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a disabled person An IT worker has won a legal battle to sue AstraZeneca ...

open image in gallery A view of the entrance sign at Östra Kyrkogården, one of the largest cemeteries in Gothenburg Sweden pursued a policy of neutrality from the early 19th Century, including ...

Digital healthcare consultations are not enough for a safe assessment of tonsillitis, according to a study from the University of Gothenburg. Reliability will not be sufficient, thus increasing ...

Innovation installed by AstraZeneca for advancing human heart ... with significant cost and efficiency gains BOSTON and GOTHENBURG, Sweden, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Medera Inc ...

Since then, it has expanded its services to researchers across the Nordic region. The NanoSIMS instrument is owned by the University of Gothenburg and hosted by AstraZeneca as part of the open ...

"It's appalling the way AstraZeneca has been treated. I wouldn't blame them if they were thoroughly fed up and decided to bow out of the Covid vaccine business." That was the view from one of the ...